Battelle

Kimer Med Secures $1.3 Million Contract for Antiviral Drug Development

Kimer Med, a biotech startup in New Zealand, has secured a $1.3 million contract to advance antiviral drug development. The focus is on developing new antiviral drug candidates for the treatment of alphaviruses, which can cause significant human and animal disease. Kimer Med has shown progress in developing antivirals with efficacy against various viruses, including Dengue and Zika.